MedTech
Medtronic Completes $550M Acquisition of Scientia Vascular to Advance Neurovascular Care
Galway-headquartered Medtronic has completed its $550 million acquisition of Scientia Vascular, integrating best-in-class guidewires and catheters into its neurovascular portfolio to transform stroke treatment globally.
Industry
Prime Minister Carney Expands Canada-Ireland Partnership in Science, Technology, and Pharma
Canadian Prime Minister Mark Carney's landmark visit to Ireland strengthens bilateral cooperation in artificial intelligence, biomanufacturing, and resilient health systems, highlighting massive new investments in the life science sector.
Industry
Europe's United Front: How the Beneluxa Initiative is Defending the Pharma Framework Against US Pricing Pressure
With the US pushing for individual drug pricing deals and Germany slashing healthcare spending, the Beneluxa Initiative represents five European nations calling for a unified, coordinated approach to protect Europe's pharmaceutical innovation and access to medicines in 2026.
Industry
Fueling Prosperity: How Ireland is Leveraging its Economic Boom for Future Generations
A positive look at the June 2026 Fiscal Assessment Report, highlighting Ireland's strategic investments, robust corporate tax windfalls, and bold plans for infrastructure and savings funds.
MedTech
EU-India FTA: A New Era of Trade Creating a 2 Billion People Free Trade Zone
Discover how the monumental EU-India Free Trade Agreement creates a market of 2 billion people. Explore its impact on tech, education, and how it will specifically propel Ireland's pharmaceutical and life sciences sector.
Regulatory Affairs
The GLP-1 Dilemma: Ireland’s Battle Over Blockbuster Weight-Loss Drugs
The Health Service Executive (HSE) is facing intense budgetary pressure as clinical demand for GLP-1 obesity medications skyrockets. We break down the restrictive funding, the "dreadful dichotomy" of access, and the surge in illegal online sales.
MedTech
A Tale of Two Systems: Why US Healthcare Costs are Skyrocketing and What it Means for Ireland
A recent PwC report warns that US commercial healthcare costs will surge by 9% in 2027. We compare the driving forces behind this unprecedented American inflation with the pressures currently facing the Irish healthcare system.
Industry
The Ultimate Guide to Startup Funding in Ireland (2026)
Navigating the Irish startup ecosystem? Discover our comprehensive, step-by-step breakdown of seed funding, accelerator programs, and grants available from Enterprise Ireland, LEO, NDRC, and more in 2026.
MedTech
Emerging Pharma Companies in Ireland to Watch in 2026
Discover the top 5 high-growth Irish life science, biotech, and medtech companies transforming the healthcare landscape. From Enterprise Ireland backed startups to global scale-ups, these are the emerging leaders of 2026.
Industry
Ireland Unveils €460m Investment in Seven New "Rinn" Research Centres
The Irish Government, led by Minister James Lawless, has announced a historic €460 million investment to establish seven new national research and innovation hubs across critical sectors like AI, Pharma, and Quantum Science.
Regulatory Affairs
FDA 21 CFR Part 211 vs. EU GMP Annex 1: Key Differences
A comprehensive breakdown of the core differences between US FDA 21 CFR Part 211 and EU GMP Annex 1 for sterile and non-sterile pharmaceutical manufacturing.
Regulatory Affairs
CAPA vs. Root Cause Analysis (RCA) in Pharma
Understanding the critical distinction between Root Cause Analysis (RCA) and Corrective and Preventive Actions (CAPA) in pharmaceutical quality management systems.